Sobi is an international rare disease company dedicated to providing access to innovative treatments that make a significant difference for people with rare diseases. Sobi is an integrated biotechnology company with in-house capabilities that encompass the entire value chain, from research, to preclinical and clinical development, biologics manufacturing and supply, to patient access and distribution. This integrated approach is a prerequisite for providing proprietary drugs, and an enabler for partnerships, especially at early stages of drug development.
State of Ownership
Business Development Executive, Nature Publishing Group, Springer Nature